Variable Presentations and Ablation Sites for Manifest Nodoventricular/Nodofascicular Fibers.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
09 2019
Historique:
entrez: 12 9 2019
pubmed: 12 9 2019
medline: 24 4 2020
Statut: ppublish

Résumé

Nodofascicular and nodoventricular (NFV) accessory pathways connect the atrioventricular node and the Purkinje system or ventricular myocardium, respectively. Concealed NFV pathways participate as the retrograde limb of supraventricular tachycardia (SVT). Manifest NFV pathways can comprise the anterograde limb of wide-complex SVT but are quite rare. The purpose of this report is to highlight the electrophysiological properties and sites of ablation for manifest NFV pathways. Eight patients underwent electrophysiology studies for wide-complex tachycardia (3), for narrow-complex tachycardia (1), and preexcitation (4). NFV was an integral part of the SVT circuit in 3 patients. Cases 1 to 2 were wide-complex tachycardia because of manifest NFV SVT. Case 3 was a bidirectional NFV that conducted retrograde during concealed NFV SVT and anterograde causing preexcitation during atrial pacing. NFV was a bystander during atrioventricular node re-entrant tachycardia, atrial fibrillation, atrial flutter, and orthodromic atrioventricular re-entrant tachycardia in 4 cases and caused only preexcitation in 1. Successful NFV ablation was achieved empirically in the slow pathway region in 1 case. In 5 cases, the ventricular insertion was mapped to the slow pathway region (2 cases) or septal right ventricle (3 cases). The NFV was not mapped in cases 5 and 7 because of its bystander role. QRS morphology of preexcitation predicted the right ventricle insertion sites in 4 of the 5 cases in which it was mapped. During follow-up, 1 patient noted recurrent palpitations but no documented SVT. Manifest NFV may be critical for wide-complex tachycardia/manifest NFV SVT, act as the retrograde limb for narrow-complex tachycardia/concealed NFV SVT, or cause bystander preexcitation. Ablation should initially target the slow pathway region, with mapping of the right ventricle insertion site if slow pathway ablation is not successful. The QRS morphology of maximal preexcitation may be helpful in predicting successful right ventricle ablation site.

Sections du résumé

BACKGROUND
Nodofascicular and nodoventricular (NFV) accessory pathways connect the atrioventricular node and the Purkinje system or ventricular myocardium, respectively. Concealed NFV pathways participate as the retrograde limb of supraventricular tachycardia (SVT). Manifest NFV pathways can comprise the anterograde limb of wide-complex SVT but are quite rare. The purpose of this report is to highlight the electrophysiological properties and sites of ablation for manifest NFV pathways.
METHODS
Eight patients underwent electrophysiology studies for wide-complex tachycardia (3), for narrow-complex tachycardia (1), and preexcitation (4).
RESULTS
NFV was an integral part of the SVT circuit in 3 patients. Cases 1 to 2 were wide-complex tachycardia because of manifest NFV SVT. Case 3 was a bidirectional NFV that conducted retrograde during concealed NFV SVT and anterograde causing preexcitation during atrial pacing. NFV was a bystander during atrioventricular node re-entrant tachycardia, atrial fibrillation, atrial flutter, and orthodromic atrioventricular re-entrant tachycardia in 4 cases and caused only preexcitation in 1. Successful NFV ablation was achieved empirically in the slow pathway region in 1 case. In 5 cases, the ventricular insertion was mapped to the slow pathway region (2 cases) or septal right ventricle (3 cases). The NFV was not mapped in cases 5 and 7 because of its bystander role. QRS morphology of preexcitation predicted the right ventricle insertion sites in 4 of the 5 cases in which it was mapped. During follow-up, 1 patient noted recurrent palpitations but no documented SVT.
CONCLUSIONS
Manifest NFV may be critical for wide-complex tachycardia/manifest NFV SVT, act as the retrograde limb for narrow-complex tachycardia/concealed NFV SVT, or cause bystander preexcitation. Ablation should initially target the slow pathway region, with mapping of the right ventricle insertion site if slow pathway ablation is not successful. The QRS morphology of maximal preexcitation may be helpful in predicting successful right ventricle ablation site.

Identifiants

pubmed: 31505948
doi: 10.1161/CIRCEP.119.007337
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e007337

Auteurs

Babak Nazer (B)

Knight Cardiovascular Institute, Oregon Health & Sciences University, Portland (B.N., T.A.D.).

Tomos E Walters (TE)

Cardiology Division (T.E.W., B.K.L., E.P.G., M.M.S.), University of California San Francisco.

Thomas A Dewland (TA)

Knight Cardiovascular Institute, Oregon Health & Sciences University, Portland (B.N., T.A.D.).

Aditi Naniwadekar (A)

Division of Cardiology, East Carolina University; Greenville, NC (A.N.).

Jacob S Koruth (JS)

Cardiology Division, Mount Sinai Medical Center; New York (J.S.K.).

Mohammed Najeeb Osman (M)

Division of Cardiology, Louis Stokes Cleveland Veterans Affairs Medical Center & Case Western Reserve University, OH (M.N.O., A.I.).

Anselma Intini (A)

Division of Cardiology, Louis Stokes Cleveland Veterans Affairs Medical Center & Case Western Reserve University, OH (M.N.O., A.I.).

Minglong Chen (M)

Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, China (M.C.).

Jurgen Biermann (J)

Department of Cardiology and Angiology, Heart Center Freiburg University, Germany (J.B., J.S.).

Johannes Steinfurt (J)

Department of Cardiology and Angiology, Heart Center Freiburg University, Germany (J.B., J.S.).

Jonathan M Kalman (JM)

Department of Cardiology, Royal Melbourne Hospital, Parkville, Australia (J.M.K.).

Ronn E Tanel (RE)

Pediatric Cardiology Division (R.E.T.), University of California San Francisco.

Byron K Lee (BK)

Cardiology Division (T.E.W., B.K.L., E.P.G., M.M.S.), University of California San Francisco.

Nitish Badhwar (N)

Division of Cardiology, Stanford University, CA (N.B.).

Edward P Gerstenfeld (EP)

Cardiology Division (T.E.W., B.K.L., E.P.G., M.M.S.), University of California San Francisco.

Melvin M Scheinman (MM)

Cardiology Division (T.E.W., B.K.L., E.P.G., M.M.S.), University of California San Francisco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH